LBX Pharmacy Chain Joint Stock Company (SHA:603883)
China
· Delayed Price · Currency is CNY 14.14
+0.27 (1.95%)
Apr 29, 2026, 2:05 PM CST
SHA:603883 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 22,283 | 22,237 | 22,213 | 22,288 | 20,055 | 15,579 | Upgrade
|
| Other Revenue | - | - | 144.48 | 149.26 | 120.29 | 117.11 | Upgrade
|
| Revenue | 22,283 | 22,237 | 22,358 | 22,437 | 20,176 | 15,696 | Upgrade
|
| Revenue Growth (YoY) | 0.13% | -0.54% | -0.36% | 11.21% | 28.54% | 12.38% | Upgrade
|
| Cost of Revenue | 15,124 | 15,055 | 14,946 | 15,157 | 13,751 | 10,659 | Upgrade
|
| Gross Profit | 7,159 | 7,182 | 7,412 | 7,280 | 6,425 | 5,037 | Upgrade
|
| Selling, General & Admin | 5,945 | 5,987 | 6,205 | 5,753 | 5,005 | 3,990 | Upgrade
|
| Research & Development | 54.76 | 51.07 | 2.01 | 2.51 | 2.23 | - | Upgrade
|
| Other Operating Expenses | 0.77 | -1.32 | 33.68 | 46.21 | 38.51 | 14.95 | Upgrade
|
| Operating Expenses | 6,001 | 6,037 | 6,247 | 5,811 | 5,053 | 4,010 | Upgrade
|
| Operating Income | 1,158 | 1,145 | 1,165 | 1,469 | 1,371 | 1,027 | Upgrade
|
| Interest Expense | - | - | -178.25 | -185.6 | -232.14 | -192.13 | Upgrade
|
| Interest & Investment Income | 0.17 | 0.9 | 22.83 | 93.87 | 51.35 | 37.14 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | -1.25 | -5.22 | -16.91 | 4.8 | Upgrade
|
| Other Non Operating Income (Expenses) | -126.96 | -134.63 | -13.65 | -14.61 | -13.4 | -14.44 | Upgrade
|
| EBT Excluding Unusual Items | 1,031 | 1,011 | 994.5 | 1,357 | 1,160 | 861.9 | Upgrade
|
| Impairment of Goodwill | - | - | -107.54 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -1.5 | 5.77 | 10.47 | Upgrade
|
| Gain (Loss) on Sale of Assets | -3.87 | -3.54 | -4.53 | 5.51 | 1.44 | 4.66 | Upgrade
|
| Asset Writedown | -251.17 | -251.36 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | 33.54 | 46.69 | 40.21 | 84.95 | Upgrade
|
| Pretax Income | 775.75 | 756.17 | 915.97 | 1,408 | 1,208 | 961.99 | Upgrade
|
| Income Tax Expense | 220.67 | 215.72 | 230.85 | 284.27 | 231.37 | 175.26 | Upgrade
|
| Earnings From Continuing Operations | 555.08 | 540.45 | 685.12 | 1,124 | 976.24 | 786.73 | Upgrade
|
| Minority Interest in Earnings | -160.02 | -158.6 | -166.05 | -194.54 | -191.28 | -117.49 | Upgrade
|
| Net Income | 395.07 | 381.85 | 519.06 | 929.02 | 784.96 | 669.24 | Upgrade
|
| Net Income to Common | 395.07 | 381.85 | 519.06 | 929.02 | 784.96 | 669.24 | Upgrade
|
| Net Income Growth | -11.90% | -26.43% | -44.13% | 18.35% | 17.29% | 7.75% | Upgrade
|
| Shares Outstanding (Basic) | 762 | 764 | 763 | 755 | 750 | 707 | Upgrade
|
| Shares Outstanding (Diluted) | 762 | 764 | 763 | 755 | 750 | 707 | Upgrade
|
| Shares Change (YoY) | 0.04% | 0.05% | 1.06% | 0.67% | 6.08% | 2.42% | Upgrade
|
| EPS (Basic) | 0.52 | 0.50 | 0.68 | 1.23 | 1.05 | 0.95 | Upgrade
|
| EPS (Diluted) | 0.52 | 0.50 | 0.68 | 1.23 | 1.05 | 0.95 | Upgrade
|
| EPS Growth | -11.94% | -26.47% | -44.71% | 17.57% | 10.57% | 5.20% | Upgrade
|
| Free Cash Flow | 2,963 | 2,889 | 1,519 | 2,109 | 2,006 | 1,820 | Upgrade
|
| Free Cash Flow Per Share | 3.89 | 3.78 | 1.99 | 2.79 | 2.67 | 2.57 | Upgrade
|
| Dividend Per Share | - | - | 0.411 | 0.508 | 0.385 | 0.296 | Upgrade
|
| Dividend Growth | - | - | -19.11% | 32.01% | 30.02% | 42.83% | Upgrade
|
| Gross Margin | 32.13% | 32.30% | 33.15% | 32.45% | 31.84% | 32.09% | Upgrade
|
| Operating Margin | 5.20% | 5.15% | 5.21% | 6.55% | 6.80% | 6.54% | Upgrade
|
| Profit Margin | 1.77% | 1.72% | 2.32% | 4.14% | 3.89% | 4.26% | Upgrade
|
| Free Cash Flow Margin | 13.30% | 12.99% | 6.79% | 9.40% | 9.94% | 11.59% | Upgrade
|
| EBITDA | 1,446 | 1,412 | 1,345 | 1,662 | 1,533 | 1,162 | Upgrade
|
| EBITDA Margin | 6.49% | 6.35% | 6.01% | 7.41% | 7.60% | 7.41% | Upgrade
|
| D&A For EBITDA | 288.73 | 266.95 | 179.84 | 193.69 | 161.87 | 135.67 | Upgrade
|
| EBIT | 1,158 | 1,145 | 1,165 | 1,469 | 1,371 | 1,027 | Upgrade
|
| EBIT Margin | 5.20% | 5.15% | 5.21% | 6.55% | 6.80% | 6.54% | Upgrade
|
| Effective Tax Rate | 28.44% | 28.53% | 25.20% | 20.19% | 19.16% | 18.22% | Upgrade
|
| Revenue as Reported | - | - | 22,358 | 22,437 | 20,176 | 15,696 | Upgrade
|
| Advertising Expenses | - | - | 115.57 | 117.99 | 94.5 | 109.84 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.